Side-by-side comparison

CompareIktosvsCradle

Compare tools

2 of 4 tools selected

AI Drug Discovery & Protein/Molecule Design Software

Iktos

Generative chemistry and synthesis planning AI

SF Score
7.4/10
Pricing
Contact sales
AI Drug Discovery & Protein/Molecule Design Software

Cradle

AI protein design for wet labs

SF Score
7.5/10
Pricing
Contact sales
Add third toolCompare up to 4 side by side

Compare features, strengths, trade-offs, and best-fit use cases.

Where each one leads

Read straight from the published figures below — not a ranking, and not a recommendation.

  • Highest SF Score

    Cradle7.5/10

    2 of 2 are scored

At a glance

The short version

The facts each tool publishes, lined up so you can scan down a column. Anything the catalog does not establish is marked as such rather than counted against the tool.

Iktos

SF Score
7.4 / 10
Free plan
Not offered
Category
AI Healthcare & Medical Software › AI Drug Discovery & Protein/Molecule Design Software

Cradle

SF Score
7.5 / 10
Free plan
Not offered
Category
AI Healthcare & Medical Software › AI Drug Discovery & Protein/Molecule Design Software

Key differences

Where these tools actually diverge

The decision dimensions that separate this set, with each tool's own position stated plainly. No winner is declared — fit depends on your workflow.

Positioned for

Iktos

AI Drug Discovery & Protein/Molecule Design Software

Cradle

AI Drug Discovery & Protein/Molecule Design Software

Pricing model

Iktos

Contact sales

Cradle

Contact sales

SoftFinders Score

Iktos

7.4 / 10

Cradle

7.5 / 10

Feature comparison

Capability matrix

Grouped by area. Every state carries a word as well as a colour, and anything the catalog has not established stays neutral rather than counting as a missing feature.

1 row differs 6 identical

Capability comparison across the selected tools. Each row is a capability; each column is a tool.
Capability IktosCradle
Overview
SF Score7.4 / 10Value7.5 / 10Value
Pricing modelCustomValueCustomValue
Free planNoNo
CategoryAI Healthcare & Medical Software › AI Drug Discovery & Protein/Molecule Design SoftwareValueAI Healthcare & Medical Software › AI Drug Discovery & Protein/Molecule Design SoftwareValue
Core features
Target DiscoveryIdentifies potential drug targets from biological dataYesYes
Virtual ScreeningScreens compound libraries against targetsYesYes
Literature IntelligenceMines biomedical literature for relevant evidenceYesYes

Scroll the matrix sideways to see every column.

Listed by one tool only

8 capabilities are published by a single tool in this set. That does not mean the others lack them — only that the catalog has not established an answer either way.

Use cases

What each tool is built for

The workflows each tool publishes for itself. Cards appear only for tools that list use cases.

Iktos

  • Bridge AI design and wet lab cycles
  • Identify drug targets from biology data
  • Accelerate molecule design cycles
  • Support protein engineering programs
  • Mine literature for research signals

+1 more on the Iktos profile

Cradle

  • Support protein engineering programs
  • Mine literature for research signals
  • Run virtual screens against targets
  • Collaborate with pharma partners
  • Bridge AI design and wet lab cycles

+5 more on the Cradle profile

Pros & cons

Strengths and compromises

Each tool's published strengths and the compromises that come with them, as supplied — not scored or ranked against each other. Longer lists fold; nothing is left out.

Iktos

Pros

  • Generative chemistry plus synthesis planning
  • Built specifically for drug discovery teams, not bolt-on AI
  • Scales to organization-wide healthcare rollouts

Cons

  • Engagement is partnership and software-led
  • Drug success still depends on downstream trials
  • Pricing is sales-led and needs scoping upfront

Cradle

Pros

  • Accessible protein design for wet labs
  • Concentrates on drug discovery depth over broad coverage
  • Scales to organization-wide healthcare rollouts
  • SOC 2 and ISO 27001 certified

Cons

  • Best value needs in-house protein programs
  • Drug success still depends on downstream trials
  • Pricing is sales-led and needs scoping upfront

Pricing

What each one costs

Published pricing signals only. Where a tool has not established a price, that is what it says — never a zero and never "free".

Next step

Ready to try one?

A matrix narrows the field; a free trial settles it. Open whichever tool fits your workflow best, or start a different comparison.

Compare another set of tools